Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis

NCT01100034

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Centre Hospitalier Victor Dupouy / Service de Dermatologie Argenteuil, France
  • CHRU Tours Hopital Trousseau Chambray-lès-Tours, France
  • CHU de Nantes - Hôtel Dieu Nantes, France
  • CH Quimper Cornouaille Quimper, France
View all 29 locations
View Trial Details
Completed

A Phase 3 Study in Participants With Moderate to Severe Psoriasis

NCT01474512

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fremont, California, United States
View all 104 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

NCT02326272

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0002 203 Phoenix, Arizona, United States
  • Ps0002 214 Bakersfield, California, United States
  • Ps0002 212 Santa Monica, California, United States
  • Ps0002 204 Ormond Beach, Florida, United States
View all 23 locations
View Trial Details
Completed

A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

NCT03090100

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Southern California Permanente Medical Group Los Angeles, California, United States
  • Dermatology Specialists Oceanside, California, United States
  • MedDerm Associates San Diego, California, United States
View all 142 locations
View Trial Details
Completed

The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With Eczema

NCT03873142

Conditions
Dermatitis, Eczema, Psoriasis, +5 more
Locations
  • Barnsley Hospital NHS Foundation Trust Barnsley, South Yorkshire, United Kingdom
  • The University of Sheffield Sheffield, South Yorkshire, United Kingdom
  • Sheffield Children's Hospital Sheffield, South Yorkshire, United Kingdom
  • Doncaster Royal Infirmary Doncaster, United Kingdom
View Trial Details
Completed

A Study in Participants With Moderate to Severe Psoriasis

NCT01107457

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Haven, Connecticut, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Washington D.C., District of Columbia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
View all 34 locations
View Trial Details

Related conditions